Generic Name: Amlodipine 5mg + Olmesartan Medoxomil 20mg Manufacturer/Distributor: Square Pharmaceuticals Limited
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Indications
Two medications, both of which help to control high blood pressure, are present in Camlosart 5/20. Your likelihood of experiencing a heart attack or stroke in the future is decreased by lowering blood pressure. You can take Camlosart on 5/20 with food or on an empty stomach. It is best to take it regularly, as directed by your doctor, at a set time each day.
Pharmacology
Amlodipine is a dihydropyridine calcium channel blocker that prevents calcium ions from passing through the membrane into the myocardium and vascular smooth muscle. Amlodipine has a greater impact on vascular smooth muscle cells than it does on cardiomyocytes. Amlodipine reduces peripheral vascular resistance and blood pressure by directly acting on vascular smooth muscle, which is how it works as a peripheral arterial vasodilator.
The angiotensin-converting enzyme catalyzes the reaction that results in the formation of angiotensin II from angiotensin I. (ACE). It is the primary vasoactive hormone of the renin-angiotensin system and a potent vasoconstrictor. It has high blood pressure as well. a crucial aspect of pathophysiology. Additionally, it induces aldosterone secretion from the adrenal cortex.
Olmesartan medoxomil selectively prevents angiotensin II from binding to AT1 receptors found in numerous tissues, preventing angiotensin II from constricting blood vessels and secreting aldosterone (such as vascular smooth muscle, and adrenal glands). Olmesartan Medoxomil is a competitive and reversible AT1 receptor inhibitor, according to in vitro binding studies. Olmesartan medoxomil doesn't stop ACE from working (kinase II, an enzyme that converts angiotensin I into angiotensin II and breaks down bradykinin).
Dosage & Administration
Initial Treatment One tablet (5/20 mg) taken once daily is the typical starting dose for CamlosartTM. After one to two weeks of therapy, the dosage can be increased to a maximum of 10/40 mg once daily as needed to control blood pressure. You can take CamlosartTM with or without food. It is possible to combine CamlosartTM with other antihypertensive medications. Patients older than 75 or with hepatic impairment should not begin treatment with this combination product. Treatment Replacement
To replace each of its individually titrated components, use CamlosartTM. If blood pressure control has not been successful when using individual components, the dose of one or both of the components may need to be increased. Extension Therapy
For patients whose blood pressure cannot be sufficiently controlled by Amlodipine (or another dihydropyridine calcium channel blocker) alone or by Olmesartan Medoxomil (or another angiotensin II receptor blocker) alone, CamlosartTM may be used.
Interaction
The pharmacokinetics of Amlodipine and Olmesartan Medoxomil is not altered when the drugs are co-administered. No drug interaction studies have been conducted with Amlodipine and Olmesartan combination tablets and other drugs, although studies have been conducted with the individual Amlodipine and Olmesartan Medoxomil components and no significant drug interactions have been observed.
Contraindications
Hypersensitivity to any of the components of this combination product.
Side Effects
Pregnancy & Lactation
Pregnancy: When pregnancy is detected, discontinue this combination product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.
Nursing Mothers: Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, considering the importance of the drug to the mother.
Children: The safety and effectiveness of pediatric patients have not been established.
Precautions & Warnings
Fetal/Neonatal Morbidity and Mortality: This combination medications should be stopped as soon as pregnancy is discovered. Patients who are volume- or salt-depleted may experience symptomatic hypotension after treatment begins. Vasodilation: Use caution when giving this combination to patients, especially those who have severe aortic stenosis. When starting calcium channel blocker therapy or when the dosage is increased, patients with severe occlusive coronary artery disease may experience an increase in the frequency, duration, or severity of angina or an acute MI. Calcium channel blockers should only be used with extreme caution in patients with congestive heart failure. Use with caution in patients with impaired renal function or hepatic impairment.
Storage Conditions
Store in a cool and dry place, protect from light and moisture. Store at 250 C. Keep out of the reach of children
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.